Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Bang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cardiology|August 15, 2016
Prevalence and significance of troponin elevations in patients without acute coronary diseaseKirstine Roll Vestergaard, Camilla Bang Jespersen, Asthildur Arnadottir, et al.
The American Journal of Emergency Medicine|June 15, 2023
NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients - A prospective clinical studyCecilie Budolfsen, Anders Sjørslev Schmidt, Kasper Glerup Lauridsen, et al.
European Heart Journal|May 13, 2019
Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortalityPeter E Weeke, Jesper S Kellemann, Camilla Bang Jespersen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cardiology|August 15, 2016
Prevalence and significance of troponin elevations in patients without acute coronary diseaseKirstine Roll Vestergaard, Camilla Bang Jespersen, Asthildur Arnadottir, et al.
The American Journal of Emergency Medicine|June 15, 2023
NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients - A prospective clinical studyCecilie Budolfsen, Anders Sjørslev Schmidt, Kasper Glerup Lauridsen, et al.
European Heart Journal|May 13, 2019
Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortalityPeter E Weeke, Jesper S Kellemann, Camilla Bang Jespersen, et al.
Pageof 2